Facebook
X
LinkedIn
Forward
Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2025 - Sept. 20, 2025
In-Person and Virtual attendance options are available.
Presented by the Sherrie and Alan Conover Center for Liver Disease & Transplantation at Houston Methodist
The epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.
This activity will provide lecture format presentations, debate and panel discussions, Q&A sessions and case discussions.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (Houston Methodist) | $25 |
| Physician (Private physician located within the Greater Houston Area)* | $255 |
| Physician (Private physician located outside the Greater Houston Area) | $50 |
| Allied Health Care Professional (including Nurses) | $20 |
| Resident / Fellow / Student | Complimentary |
*In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Presenters, topics, program schedule, and credit is subject to change
Target Audience
This conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse practitioners, and physician assistants and other health care providers.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Provide significant information regarding new and critical developments in portal hypertension.
- Identify emerging trends in the Metabolic Dysfunction Associated Fatty Liver Disease (MASLD) and determine the latest concepts in diagnosis and management.
- Explain innovations occurring in the management of liver diseases, including viral hepatitis.
- Discuss current new developments and treatment of liver cancers –an emerging epidemic.
| Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2025 | ||
| AGENDA | Saturday, September 20 | ||
| TIME | PRESENTATION | SPEAKER(S) |
| 7:00 AM | Registration & Breakfast | |
| 7:30 AM | Conference Welcome | Victor Ankoma-Sey, MD, FACP, FAASLD |
| 7:40 AM | Introductory Remarks | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| PLENARY SESSION I: Unique Complications of Portal Hypertension Moderators: Chukwuma Egwim, MD, Joseph Galati, MD and Ashish Saharia, MD | ||
| 7:50 AM | Drug induced liver injury in the patient with Chronic liver disease | Naga Chalasani, MD |
| 8:20 AM | State of the Art Lecture I Management of Coagulopathy & Bleeding Diathesis in the patient with Cirrhosis | Patrick Northup, MD |
| 8:50 AM | From Risk to Recognition: Addressing Emerging Threats to Improve Prevention and Detection of HCC | Cynthia Ann Moylan, MD, MHS, MS |
| 9:10 AM | Q&A and Discussion | |
| 9:25 AM | BREAK | |
| PLENARY SESSION II: Advances in Metabolic Dysfunction-Associated Fatty liver Disease (MASLD) - What's New? Moderators: Victor Ankoma-Sey, MD, Tamneet Basra, MD and Constance Mobley, MD | ||
| 9:40 AM | Endocrine Aspects of MASLD & Obesity: 2025 Update | Arun Sanyal, MD |
| 10:10 AM | Noninvasive Assessment of Fibrosis in MASLD | Elliot Tapper, MD |
| 10:40 AM | State of the Art Lecture II Current and Future Treatment Options of MASLD | Manal Abdelmalek, MD |
| 11:10 AM | The patient with MASLD and concomitant Alcohol Associated Liver Disease or HBV or HCV – What to do? | Michelle Jones Pauley, DO , MS |
| 11:30 AM | Q&A and Discussion | |
| 11:45 AM | LUNCH | |
| 11:45 AM | PRODUCT THEATRE (Presented in Boardroom) *Not certified for CE credit | Fernando Membreno, MD |
| PLENARY SESSION III: Current Innovations in Liver Disease Moderators: Mark Ghobrial, MD, Caroline Simon, MD & Andrea Duchini, MD | ||
| 12:45 PM | State of the Art Lecture III The Future of Liver transplantation | R. Mark Ghobrial, MD, PhD |
| 1:05 PM | Role of Artificial Intelligence (AI) in the management of liver disease | David Victor III, MD |
| 1:25 PM | Living Donor Liver Transplant – A new Era | Yee Lee Cheah, MD, FACS |
| 1:45 PM | The role of liver transplantation in the management of Cholangiocarcinoma | Ashton Connor, MD |
| 2:15 PM | Q&A and Discussion | |
| 2:30 PM | BREAK | |
| PLENARY SESSION IV: Liver Cancer- Current Concepts Moderators: Sudha Kodali, MD, Julie Corkrean & Julie Luczon | ||
| 2:45 PM | Surveillance & Diagnosis of Hepatocellular Cancer – What is new? | Lewis Roberts, MB, ChB, PHD |
| 3:15 PM | State of the Art Lecture IV Management of Hepatocellular carcinoma- Role of immunotherapy | Ahmed Omar Kaseb, MD, CMQ |
| 3:45 PM | Current and Future Management of Cholangiocarcinoma, a model for personalized Medicine? | Sudha Kodali, MD |
| 4:15 PM | Q&A and Discussion | |
| 4:30 PM | CONCLUDING REMARKS | |
In-Person attendance will be held in the Houston Methodist Research Institute (6670 Bertner Avenue, Houston, Texas 77030).
Virtual information will be provided to registered learners.
| COURSE DIRECTOR |
| Victor Ankoma-Sey, MD, FACP, FAASLD |
| Director, Liver Transplant Program Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Director, Liver Associates of Texas, PA |
Available Credit
- 7.25 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 7.25 Attendance
- 7.25 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award up to 7.25 nursing professional development contact hours for this activity.
- 7.25 Transplant CoordinatorsThe American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2025 - Sept. 20, 2025 | Tue, 04/22/2025 - 8:00am | 7.25 Category 1 CEPTCs
Interested in exhibiting? Contact us for more information.
Exhibitors
We gratefully acknowledge the following companies for participating as exhibitors for this activity:
Abbvie
Boehringer Ingelheim
Eisai
Gilead
Intercept
Ipsen
Madrigal Pharmaceuticals
Mallinckrodt
Merck
Mirum Pharmaceuticals
Novo Nordisk
Orphalan
Perspectum
Salix
Sponsors
We gratefully acknowledge the following companies for participating as sponsors for this activity:
Gilead - Breakfast Sponsor
Madrigal - Product Theater Sponsor
Price
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (Houston Methodist) | $25 |
| Physician (Private physician located within the Greater Houston Area)* | $255 |
| Physician (Private physician located outside the Greater Houston Area) | $50 |
| Allied Health Care Professional (including Nurses) | $20 |
| Resident / Fellow / Student | Complimentary |
*In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.